Publications 2019

Hagberg G, Fure B, Sandset EC, Thommessen B, Ihle-Hansen H, Øksengård AR, Nygård S, Wyller TB, Ihle-Hansen H (2019)
Long-term effects on survival after a 1-year multifactorial vascular risk factor intervention after stroke or TIA: secondary analysis of a randomized controlled trial, a 7-year follow-up study
Vasc Health Risk Manag, 15, 11-18
DOI 10.2147/VHRM.S191873, PubMed 30799926

Sandset EC, Fischer U (2019)
Blood pressure lowering in acute ischaemic stroke thrombolysis
Lancet, 393 (10174), 849-850
DOI 10.1016/S0140-6736(19)30196-5, PubMed 30739748

Publications 2018

Sandset EC, Sanossian N, Woodhouse LJ, Anderson C, Berge E, Lees KR, Potter JF, Robinson TG, Sprigg N, Wardlaw JM, Bath PM, Blood pressure in Acute Stroke Collaboration Investigators (2018)
Protocol for a prospective collaborative systematic review and meta-analysis of individual patient data from randomized controlled trials of vasoactive drugs in acute stroke: The Blood pressure in Acute Stroke Collaboration, stage-3
Int J Stroke, 13 (7), 759-765
DOI 10.1177/1747493018772733, PubMed 29720045

Wang X, You S, Sato S, Yang J, Carcel C, Zheng D, Yoshimura S, Anderson CS, Sandset EC, Robinson T, Chalmers J, Sharma VK (2018)
Current status of intravenous tissue plasminogen activator dosage for acute ischaemic stroke: an updated systematic review
Stroke Vasc Neurol, 3 (1), 28-33
DOI 10.1136/svn-2017-000112, PubMed 29600005

Publications 2017

Cordonnier C, Sprigg N, Sandset EC, Pavlovic A, Sunnerhagen KS, Caso V, Christensen H, Women Initiative for Stroke in Europe (WISE) group (2017)
Stroke in women - from evidence to inequalities
Nat Rev Neurol, 13 (9), 521-532
DOI 10.1038/nrneurol.2017.95, PubMed 28731036

Delcourt C, Sato S, Zhang S, Sandset EC, Zheng D, Chen X, Hackett ML, Arima H, Hata J, Heeley E, Al-Shahi Salman R, Robinson T, Davies L, Lavados PM, Lindley RI, Stapf C, Chalmers J, Anderson CS, INTERACT2 Investigators (2017)
Intracerebral hemorrhage location and outcome among INTERACT2 participants
Neurology, 88 (15), 1408-1414
DOI 10.1212/WNL.0000000000003771, PubMed 28235817

Krishnan K, Jusufovic M, Sandset PM, Sandset EC (2017)
Antiplatelet Therapy in Noncardioembolic Stroke: A Review of Current Evidence
Semin Neurol, 37 (3), 366-375
DOI 10.1055/s-0037-1603469, PubMed 28759917

Sandset EC, Fischer U (2017)
Intensive blood pressure lowering provides no additional benefits and results in more adverse events
Evid Based Med, 22 (3), 102
DOI 10.1136/ebmed-2016-110594, PubMed 28546145

Schmidt A, Katan M, Sandset EC (2017)
Why Is It Worthwhile to Get Involved in Stroke Organizations?
Stroke, 48 (10), e277-e279
DOI 10.1161/STROKEAHA.117.018850, PubMed 28904230

Publications 2016

Carcel C, Wang X, Sato S, Stapf C, Sandset EC, Delcourt C, Arima H, Robinson T, Lavados P, Chalmers J, Anderson CS, INTERACT2 Investigators* (2016)
Degree and Timing of Intensive Blood Pressure Lowering on Hematoma Growth in Intracerebral Hemorrhage: Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial-2 Results
Stroke, 47 (6), 1651-3
DOI 10.1161/STROKEAHA.116.013326, PubMed 27143274

Jusufovic M, Mishra NK, Lansberg MG, Bath PM, Berge E, Sandset EC (2016)
Blood Pressure Management in Acute Stroke
Curr Hypertens Rev, 12 (2), 121-6
DOI 10.2174/1573402112666160302102711, PubMed 26931471

Jusufovic M, Sandset EC, Bath PM, Berge E, Scandinavian Candesartan Acute Stroke Trial (SCAST) Study Group (2016)
Early blood pressure lowering treatment in acute stroke. Ordinal analysis of vascular events in the Scandinavian Candesartan Acute Stroke Trial (SCAST)
J Hypertens, 34 (8), 1594-8
DOI 10.1097/HJH.0000000000000980, PubMed 27228435

Jusufovic M, Sandset EC, Skagen K, Skjelland M (2016)
Blood Pressure Lowering Treatment in Patients with Carotid Artery Stenosis
Curr Hypertens Rev, 12 (2), 148-55
DOI 10.2174/157340211202160525010133, PubMed 27292176

Qiu M, Sato S, Zheng D, Wang X, Carcel C, Hirakawa Y, Sandset EC, Delcourt C, Arima H, Wang J, Chalmers J, Anderson CS, INTERACT Investigators* (2016)
Admission Heart Rate Predicts Poor Outcomes in Acute Intracerebral Hemorrhage: The Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial Studies
Stroke, 47 (6), 1479-85
DOI 10.1161/STROKEAHA.115.012382, PubMed 27165954

Song L, Sandset EC, Arima H, Heeley E, Delcourt C, Chen G, Yang J, Wu G, Wang X, Lavados PM, Huang Y, Stapf C, Wang J, Robinson TG, Chalmers J, Lindley RI, Anderson CS, INTERACT2 Investigators (2016)
Early blood pressure lowering in patients with intracerebral haemorrhage and prior use of antithrombotic agents: pooled analysis of the INTERACT studies
J Neurol Neurosurg Psychiatry, 87 (12), 1330-1335
DOI 10.1136/jnnp-2016-313246, PubMed 27178897

Wang X, Cao Y, Hong D, Zheng D, Richtering S, Sandset EC, Leong TH, Arima H, Islam S, Salam A, Anderson C, Robinson T, Hackett ML (2016)
Ambient Temperature and Stroke Occurrence: A Systematic Review and Meta-Analysis
Int J Environ Res Public Health, 13 (7)
DOI 10.3390/ijerph13070698, PubMed 27420077

Publications 2015

Berge E, Cohen G, Lindley RI, Sandercock P, Wardlaw JM, Sandset EC, Whiteley W (2015)
Effects of Blood Pressure and Blood Pressure-Lowering Treatment During the First 24 Hours Among Patients in the Third International Stroke Trial of Thrombolytic Treatment for Acute Ischemic Stroke
Stroke, 46 (12), 3362-9
DOI 10.1161/STROKEAHA.115.010319, PubMed 26486868

Hornslien AG, Sandset EC, Igland J, Terént A, Boysen G, Bath PM, Murray GD, Berge E (2015)
Effects of candesartan in acute stroke on vascular events during long-term follow-up: results from the Scandinavian Candesartan Acute Stroke Trial (SCAST)
Int J Stroke, 10 (6), 830-5
DOI 10.1111/ijs.12477, PubMed 25808741

Hornslien AG, Sandset EC, Wyller TB, Berge E, Scandinavian Candesartan Acute Stroke Trial (SCAST) Study Group (2015)
Effects of candesartan in acute stroke on activities of daily living and level of care at 6 months
J Hypertens, 33 (7), 1487-91
DOI 10.1097/HJH.0000000000000581, PubMed 26039534

Sandset EC, Jusufovic M, Sandset PM, Bath PM, Berge E, SCAST Study Group (2015)
Effects of blood pressure-lowering treatment in different subtypes of acute ischemic stroke
Stroke, 46 (3), 877-9
DOI 10.1161/STROKEAHA.114.008512, PubMed 25657183

Publications 2014

Jusufovic M, Sandset EC, Bath PM, Berge E, Scandinavian Candesartan Acute Stroke Trial Study Group (2014)
Blood pressure-lowering treatment with candesartan in patients with acute hemorrhagic stroke
Stroke, 45 (11), 3440-2
DOI 10.1161/STROKEAHA.114.006433, PubMed 25256183

Jusufovic M, Sandset EC, Bath PM, Karlson BW, Berge E, Scandinavian Candesartan Acute Stroke Trial Study Group (2014)
Effects of blood pressure lowering in patients with acute ischemic stroke and carotid artery stenosis
Int J Stroke, 10 (3), 354-9
DOI 10.1111/ijs.12418, PubMed 25472578

Jusufovic M, Sandset EC, Berge E, Scandinavian Candesartan Acute Stroke Trial Study Group (2014)
Response to letter regarding article, "Blood pressure-lowering treatment with candesartan in patients with acute hemorrhagic stroke"
Stroke, 46 (1), e14
DOI 10.1161/STROKEAHA.114.007859, PubMed 25492909

Sandset EC (2014)
Blood pressure in acute stroke
Lancet Neurol, 13 (4), 342-3
DOI 10.1016/S1474-4422(14)70042-0, PubMed 24582531

Sandset EC, Berge E, Kjeldsen SE, Julius S, Holzhauer B, Krarup LH, Hua TA (2014)
Heart rate as a predictor of stroke in high-risk, hypertensive patients with previous stroke or transient ischemic attack
J Stroke Cerebrovasc Dis, 23 (10), 2814-8
DOI 10.1016/j.jstrokecerebrovasdis.2014.07.009, PubMed 25304725

Publications 2013

Hornslien AG, Sandset EC, Bath PM, Wyller TB, Berge E, Scandinavian Candesartan Acute Stroke Trial Study Group (2013)
Effects of candesartan in acute stroke on cognitive function and quality of life: results from the Scandinavian Candesartan Acute Stroke Trial
Stroke, 44 (7), 2022-4
DOI 10.1161/STROKEAHA.113.001022, PubMed 23660849

Publications 2012

Jusufovic M, Sandset EC, Popperud TH, Solberg S, Ringstad G, Kerty E (2012)
An unusual case of the syndrome of cervical rib with subclavian artery thrombosis and cerebellar and cerebral infarctions
BMC Neurol, 12, 48
DOI 10.1186/1471-2377-12-48, PubMed 22741548

Sandset EC, Berge E (2012)
Response to Letter by Simone Vidale Regarding Article, "Relation Between Change in Blood Pressure in Acute Stroke and Risk of Early Adverse Events and Poor Outcome"
Stroke, 43 (12), E177

Sandset EC, Murray GD, Bath PM, Kjeldsen SE, Berge E, Scandinavian Candesartan Acute Stroke Trial (SCAST) Study Group (2012)
Relation between change in blood pressure in acute stroke and risk of early adverse events and poor outcome
Stroke, 43 (8), 2108-14
DOI 10.1161/STROKEAHA.111.647362, PubMed 22627991

Publications 2011

Sandset EC, Bath PM, Boysen G, Jatuzis D, Kõrv J, Lüders S, Murray GD, Richter PS, Roine RO, Terént A, Thijs V, Berge E, SCAST Study Group (2011)
The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial
Lancet, 377 (9767), 741-50
DOI 10.1016/S0140-6736(11)60104-9, PubMed 21316752

Publications 2010

Krarup LH, Sandset EC, Sandset PM, Berge E (2010)
D-dimer levels and stroke progression in patients with acute ischemic stroke and atrial fibrillation
Acta Neurol Scand, 124 (1), 40-4
DOI 10.1111/j.1600-0404.2010.01409.x, PubMed 20726843

Sandset EC, Murray G, Boysen G, Jatuzis D, Kõrv J, Lüders S, Richter PS, Roine RO, Terént A, Thijs V, Berge E, SCAST Study Group (2010)
Angiotensin receptor blockade in acute stroke. The Scandinavian Candesartan Acute Stroke Trial: rationale, methods and design of a multicentre, randomised- and placebo-controlled clinical trial (NCT00120003)
Int J Stroke, 5 (5), 423-7
DOI 10.1111/j.1747-4949.2010.00473.x, PubMed 20854630

Publications 2007

Berge E, Haug KB, Sandset EC, Haugbro KK, Turkovic M, Sandset PM (2007)
The factor V Leiden, prothrombin gene 20210GA, methylenetetrahydrofolate reductase 677CT and platelet glycoprotein IIIa 1565TC mutations in patients with acute ischemic stroke and atrial fibrillation
Stroke, 38 (3), 1069-71
DOI 10.1161/01.STR.0000258076.04860.8e, PubMed 17290027